Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Resistant hypertension (RH) is a powerful risk factor for cardiovascular morbidity and mortality. Among the characteristics of patients with RH, obesity, obstructive sleep apnea, and aldosterone excess are covering a great area of the mosaic of RH phenotype. Increased sympathetic nervous system (SNS) activity is present in all these underlying conditions, supporting its crucial role in the pathophysiology of antihypertensive treatment resistance. Current clinical and experimental knowledge points towards an impact of several factors on SNS activation, namely, insulin resistance, adipokines, endothelial dysfunction, cyclic intermittent hypoxaemia, aldosterone effects on central nervous system, chemoreceptors, and baroreceptors dysregulation. The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960 · cited 1×
“In a series of 41 resistant hypertensives, the prevalence of OSA, diagnosed by overnight polysomnographic study, was 83% and both the prevalence and the severity were significantly higher in men than in women [19].”
BackgroundHyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundHuman muscle nerve sympathetic activity at rest. Relationship to blood pressure and age
Sundlöf, G., & Wallin, B. G. (1978) · The Journal of Physiology · doi:10.1113/jphysiol.1978.sp012170 · Cited by 601
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575
Sympathetic Neural Activation in Visceral Obesity
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002) · Circulation · doi:10.1161/01.cir.0000041244.79165.25 · Cited by 557 · cited 1×
“Finally, the distribution of the adipose tissue seems to be crucial for the activation of the SNS since the central pattern of obesity with excess of visceral fat is accompanied by increased MSNA in contrast to men with peripheral obesity where MSNA is no higher than in lean men [23, 28, 29].”
BackgroundBaroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526 · cited 1×
“advanced the stage of HTN the greater is the adrenergic activity [4, 9, 10].”
BackgroundHow to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455 · cited 3×
“As regards plasma noradrenaline levels, low reproducibility, low sensitivity and biological restrictions to discriminate between increased secretion or reduced clearance of elevated circulating neurotransmitter constitute substantial limitations [81, 84].”
BackgroundMechanisms of Sympathetic Activation in Obesity-Related Hypertension
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E. (2006) · Hypertension · doi:10.1161/01.hyp.0000242642.42177.49 · Cited by 443 · cited 2×
“Finally, the distribution of the adipose tissue seems to be crucial for the activation of the SNS since the central pattern of obesity with excess of visceral fat is accompanied by increased MSNA in contrast to men with peripheral obesity where MSNA is no higher than in lean men [23, 28, 29].”
BackgroundRegional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundGender-Selective Interaction Between Aging, Blood Pressure, and Sympathetic Nerve Activity
Narkiewicz, K., Phillips, B. G., Kato, M., Hering, D., Bieniaszewski, L., & Somers, V. K. (2005) · Hypertension · doi:10.1161/01.hyp.0000160318.46725.46 · Cited by 398 · cited 1×
“A number of studies have shown that whole body sympathetic neural activity increases with aging [12–16] and indices of sympathetic activity, especially muscle sympathetic nerve activity (MSNA), become more linked to BP with older age [12, 17].”
BackgroundNeural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundCardiovascular Effects of Angiotensin Mediated by the Central Nervous System
FERRARIO, C. M., GILDENBERG, P. L., & MCCUBBIN, J. W. (1972) · Circulation Research · doi:10.1161/01.res.30.3.257 · Cited by 353
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
BRAMLAGE, P., PITTROW, D., WITTCHEN, H., KIRCH, W., BOEHLER, S., LEHNERT, H., HOEFLER, M., UNGER, T., & SHARMA, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.017 · Cited by 328 · cited 1×
“7 for overweight and grade 1, 2, and 3 obese patients, respectively, compared to those with normal weight [22].”
BackgroundVollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116542 · Cited by 321 · cited 1×
“Findings of increased MSNA after infusion of insulin in humans could suggest a triggering role of insulin for the SNS [30].”
BackgroundGallay, B. J., Ahmad, S., Xu, L., Toivola, B., & Davidson, R. C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80117-7 · Cited by 304 · cited 1×
“Since resistance to treatment is one of the reasons for uncontrolled BP, it is obvious that resistant hypertension (RH) entails a major clinical and social impact.”
BackgroundGaddam, K. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1159 · Cited by 301 · cited 1×
“Furthermore, individuals with true RH but without primary hyperaldosteronism have higher aldosterone levels than control participants [73].”
BackgroundResistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Goodfriend, T. L., & Calhoun, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000116223.97436.e5 · Cited by 279 · cited 1×
“8-fold increased risk of having RH [49, 50].”
Heart rate as marker of sympathetic activity
Grassi, G., Vailati, S., Bertinieri, G., Seravalle, G., Stella, M. L., DellʼOro, R., & Mancia, G. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00010 · Cited by 279 · cited 1×
“Furthermore, supine heart rate displays only a limited correlation with other indices of sympathetic activity, as plasma norepinephrine and sympathetic nerve traffic [82].”
BackgroundInteractions Between Leptin and the Human Sympathetic Nervous System
Eikelis, N., Schlaich, M., Aggarwal, A., Kaye, D., & Esler, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000066289.17754.49 · Cited by 271
Low-renin status in therapy-resistant hypertension: a clue to efficient treatment
Eide, I. K., Torjesen, P. A., Drolsum, A., Babovic, A., & Lilledahl, N. P. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00026 · Cited by 265 · cited 1×
“Since resistance to treatment is one of the reasons for uncontrolled BP, it is obvious that resistant hypertension (RH) entails a major clinical and social impact.”
BackgroundAldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., & Harding, S. M. (2004) · Chest · doi:10.1378/chest.125.1.112 · Cited by 260
Grassi, G., Colombo, M., Seravalle, G., Spaziani, D., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.64 · Cited by 256 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundŠtrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237
Fagius, J., & Wallin, B. G. (1993) · Clinical Autonomic Research · doi:10.1007/bf01826234 · Cited by 227 · cited 2×
“A number of studies have shown that whole body sympathetic neural activity increases with aging [12–16] and indices of sympathetic activity, especially muscle sympathetic nerve activity (MSNA), become more linked to BP with older age [12, 17].”
BackgroundGrassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., & Mancia, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00027 · Cited by 225 · cited 2×
“With the usual therapeutic options the SNS hyperactivity is blocked to the peripheral level of adrenergic receptors with the use of alpha and beta blockers and it should be mentioned once more that rising data suggest a sympathoinhibitory effect of angiotensin and mineralocorticoid receptor blocking [43, 76, 77].”
BackgroundSubcutaneous obesity is not associated with sympathetic neural activation
Alvarez, G. E., Ballard, T. P., Beske, S. D., & Davy, K. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01046.2003 · Cited by 121 · cited 1×
“Finally, the distribution of the adipose tissue seems to be crucial for the activation of the SNS since the central pattern of obesity with excess of visceral fat is accompanied by increased MSNA in contrast to men with peripheral obesity where MSNA is no higher than in lean men [23, 28, 29].”
BackgroundSympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly
Grassi, G., Seravalle, G., Bertinieri, G., Turri, C., DellʼOro, R., Stella, M. L., & Mancia, G. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018050-00012 · Cited by 99 · cited 1×
“More specifically, increased SNS activity has been documented in systole-diastolic and isolated systolic HTN [4, 5], in white coat and masked HTN [4, 6], in dipping, extreme dipping, nondipping and reverse dipping conditions [4, 7] and in pregnancy-induced HTN [4, 8].”
BackgroundThe Effects of Leptin Administration in Non‐obese Human Subjects
Mackintosh, R. M., & Hirsch, J. (2001) · Obesity Research · doi:10.1038/oby.2001.60 · Cited by 74 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundChan, J. L., Mietus, J. E., Raciti, P. M., Goldberger, A. L., & Mantzoros, C. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02684.x · Cited by 68 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
Background
Cited by
Pokushalov, E., Romanov, A., Corbucci, G., Artyomenko, S., Baranova, V., Turov, A., Shirokova, N., Karaskov, A., Mittal, S., & Steinberg, J. S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.036 · Cited by 432
ESH Position Paper: Renal denervation – an interventional therapy of resistant hypertension
Schmieder, R. E., Redon, J., Grassi, G., Kjeldsen, S. E., Mancia, G., Narkiewicz, K., Parati, G., Ruilope, L., van de Borne, P., & Tsioufis, C. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328352ce78 · Cited by 241
“This is also the case for pregnancy-induced hypertension [23], some secondary types of hypertension [24] and resistant hypertension [25].”
BackgroundSelf-citationHering, D., Marusic, P., Walton, A. S., Lambert, E. A., Krum, H., Narkiewicz, K., Lambert, G. W., Esler, M. D., & Schlaich, M. P. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.03098 · Cited by 142
Gut–Brain Axis in Regulation of Blood Pressure
Yang, T., & Zubcevic, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00845 · Cited by 74
“In addition to chronically elevated SNS activity (Tsioufis et al., 2011) accompanied by norepinephrine (NE) spillover (Tsioufis et al.”
BackgroundInfluentialSmith, S. M., Huo, T., Delia Johnson, B., Bittner, V., Kelsey, S. F., Vido Thompson, D., Noel Bairey Merz, C., Pepine, C. J., & Cooper‐DeHoff, R. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000660 · Cited by 69
Metadata
- Authors
- Tsioufis, C., Kordalis, A., Flessas, D., Anastasopoulos, I., Tsiachris, D., Papademetriou, V., & Stefanadis, C.
- Venue
- International Journal of Hypertension
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-7
- ISSN
- 2090-0384 (ISSN-L)
- 2090-0392
- OpenAlex
- W2034163551
- Cited by
- 139
- References
- 35
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.